{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:39:41Z","timestamp":1790433581424,"version":"4.1.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immune cells and other cells respond to nutrient deprivation by the classic catabolic pathway of AMPK (Adenosine monophosphate kinase). This kinase is a pivotal regulator of glucose and fatty acids metabolism, although current evidence highlights its role in immune regulation. Indeed AMPK, through activation of Foxo1 (Forkhead box O1) and Foxo3 (Forkhead box O3), can regulate FOXP3, the key gene for differentiation and homeostasis of Tregs (T regulators lymphocytes). The relevance of Tregs in the onset of T1D (Type 1 diabetes) is well-known, while their role in the pathogenesis of T2D (Type 2 diabetes) is not fully understood yet. However, several studies seem to indicate that Tregs may oppose the progression of diabetic complications by mitigating insulin resistance, atherosclerosis, and damage to target organs (as in kidney disease). Hence, AMPK and AMPK-activating agents may play a role in the regulation of the immune system. The connection between metformin and AMPK is historically known; however, this link and the possible related immune effects are less studied about SGLT2i (Sodium-glucose co-transport 2 inhibitors) and GLP1-RAs (Glucagon-like peptide-1 receptor agonists). Actual evidence shows that the negative caloric balance, induced by SGLT2i, can activate AMPK. Conversely and surprisingly, an anabolizing agent like GLP-1RAs can also upregulate this kinase through cAMP (Cyclic adenosine monophosphate) accumulation. Therefore, both these drugs can likely lead to the activation of the AMPK pathway and consequential proliferation of Tregs. These observations seem to confirm not only the metabolic but also the immunoregulatory effects of these new antidiabetic agents.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1163288","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T04:29:10Z","timestamp":1700454550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["GLP-1 RAs and SGLT2i: two antidiabetic agents associated with immune and inflammation modulatory properties through the common AMPK pathway"],"prefix":"10.3389","volume":"14","author":[{"given":"Alessio","family":"Mazzieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Basta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Calafiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00169","article-title":"Thymic versus induced regulatory T cells - who regulates the regulators","volume":"4","author":"Povoleri","year":"2013","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/82_2017_61","article-title":"CTLA-4, an essential immune-checkpoint for T-cell activation","volume":"410","author":"Chikuma","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2008.62","article-title":"Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression","volume":"86","author":"Yolcu","year":"2008","journal-title":"Immunol Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2013.00076","article-title":"Immune regulation in T1D and T2D: prospective role of foxp3+ Treg cells in disease pathogenesis and treatment","volume":"4","author":"Kornete","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-015-2080-2","article-title":"Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential","volume":"73","author":"Spitz","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21705\/mcbs.v4i1.64","article-title":"Impaired function of regulatory T cells in type 2 diabetes mellitus mol","volume":"4","author":"Kartika","year":"2020","journal-title":"Cell BioMed Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1098243","article-title":"The role behind the scenes of Tregs and Th17s in Hashimoto's thyroiditis: Toward a pivotal role of FOXP3 and BACH2","volume":"13","author":"Mazzieri","year":"2022","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imm.13178","article-title":"Control of regulatory T-cell differentiation and function by T-cell receptor signalling and Foxp3 transcription factor complexes","volume":"160","author":"Ono","year":"2020","journal-title":"Immunology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.12.004","article-title":"Foxo1 and foxo3 help foxp3","volume":"33","author":"Ohkura","year":"2010","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1884","article-title":"Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells","volume":"11","author":"Ouyang","year":"2010","journal-title":"Nat Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M705325200","article-title":"The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor","volume":"282","author":"Greer","year":"2007","journal-title":"J Biol Chem"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1748-1716.2009.01977.x","article-title":"Structure and function of AMP-activated protein kinase","volume":"196","author":"Oakhill","year":"2009","journal-title":"Acta Physiol (Oxf)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.111.255505","article-title":"AMP-activated protein kinase regulation and biological actions in the heart","volume":"111","author":"Zaha","year":"2012","journal-title":"Circ Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2014.09.004","article-title":"AMPK: positive and negative regulation, and its role in whole-body energy homeostasis","volume":"33","author":"Hardie","year":"2015","journal-title":"Curr Opin Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","article-title":"AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance","volume":"66","author":"Garcia","year":"2017","journal-title":"Mol Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1748-1716.2009.01971.x","article-title":"The regulation and function of mammalian AMPK-related kinases","volume":"196","author":"Bright","year":"2009","journal-title":"Acta Physiol (Oxf)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.8.2420","article-title":"The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism","volume":"51","author":"Hawley","year":"2002","journal-title":"Diabetes"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/db07-0381","article-title":"Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP","volume":"57","author":"Kim","year":"2008","journal-title":"Diabetes"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-022-00980-6","article-title":"The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases","volume":"30","author":"Hasanvand","year":"2022","journal-title":"Inflammopharmacology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-022-01512-w","article-title":"The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management","volume":"21","author":"Xu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.777861","article-title":"Sodium-glucose cotransporter 2 inhibitors mechanisms of action: A review","volume":"8","author":"Fonseca-Correa","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqab079","article-title":"SGLT2 inhibitors as calorie restriction mimetics: insights on longevity pathways and age-related diseases","volume":"162","author":"Hoong","year":"2021","journal-title":"Endocrinology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2021.03.004","article-title":"Changes in T helper cell-related factors in patients with type 2 diabetes mellitus after empagliflozin therapy","volume":"82","author":"Borzouei","year":"2021","journal-title":"Hum Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S309427","article-title":"Empagliflozin alleviates atherosclerosis progression by inhibiting inflammation and sympathetic activity in a normoglycemic mouse model","volume":"14","author":"Liu","year":"2021","journal-title":"J Inflammation Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.836849","article-title":"Emerging roles of sodium glucose cotransporter 2 (SGLT-2) inhibitors in diabetic cardiovascular diseases: focusing on immunity, inflammation and metabolism","volume":"13","author":"Xie","year":"2022","journal-title":"Front Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1038\/s41598-018-23420-4","article-title":"Canagliflozin inhibits interleukin-1\u03b2-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms","volume":"8","author":"Mancini","year":"2018","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16601","article-title":"Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPK\u03b1\/TGF-\u03b2\/Smad signalling in type 2 diabetic rats","volume":"25","author":"Tian","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2023.05.094","article-title":"Dapagliflozin restores diabetes-associated decline in vasculogenic capacity of endothelial progenitor cells via activating AMPK-mediated inhibition of inflammation and oxidative stress","volume":"671","author":"Luo","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/cells11162587","article-title":"Induced human regulatory T cells express the glucagon-like peptide-1 receptor","volume":"11","author":"Rode","year":"2022","journal-title":"Cells"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1643-x","article-title":"Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells","volume":"53","author":"Hadjiyanni","year":"2010","journal-title":"Diabetologia"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/cells11020308","article-title":"Emerging role of cAMP\/AMPK signaling","volume":"11","author":"Aslam","year":"2022","journal-title":"Cells"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181995","article-title":"AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases","volume":"39","author":"Lu","year":"2019","journal-title":"Biosci Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2023.111954","article-title":"Liraglutide alleviates myocardial ischemia\u2212reperfusion injury in diabetic mice","volume":"572","author":"Fang","year":"2023","journal-title":"Mol Cell Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.108.190918","article-title":"Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure","volume":"104","author":"Gundewar","year":"2009","journal-title":"Circ Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1177\/15353702231191178","article-title":"Metformin inhibits mitochondrial dysfunction and apoptosis in cardiomyocytes induced by high glucose via upregulating AMPK activity","author":"Wu","year":"2023","journal-title":"Exp Biol Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1161\/CIRCULATIONAHA.112.091215","article-title":"A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity","volume":"127","author":"Noyan-Ashraf","year":"2013","journal-title":"Circulation"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/1758-5996-6-29","article-title":"Effect of exenatide on the cardiac expression of adiponectin receptor 1 and NADPH oxidase subunits and heart function in streptozotocin-induced diabetic rats","volume":"6","author":"Guo","year":"2014","journal-title":"Diabetol Metab Syndr"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2337\/db17-1212","article-title":"Glucagon-like peptide 1 and its cleavage products are renoprotective in murine diabetic nephropathy","volume":"67","author":"Moellmann","year":"2018","journal-title":"Diabetes"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00394.2015","article-title":"The physiological role of glucagon-like peptide-1 in the regulation of renal function","volume":"310","author":"Farah","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.008649","article-title":"AMPK and AKT protein kinases hierarchically phosphorylate the N-terminus of the FOXO1 transcription factor, modulating interactions with 14-3-3 proteins","volume":"294","author":"Saline","year":"2019","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12291","article-title":"Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K\/Akt pathway","volume":"16","author":"Zhao","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"B44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev-nutr-071812-161148","article-title":"AMP-activated protein kinase: maintaining energy homeostasis at the cellular and whole-body levels","volume":"34","author":"Hardie","year":"2014","journal-title":"Annu Rev Nutr"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113614","article-title":"AMP-activated protein kinase: An energy sensor and survival mechanism in the reinstatement of metabolic homeostasis","volume":"428","author":"Sharma","year":"2023","journal-title":"Exp Cell Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1163288\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T04:29:12Z","timestamp":1700454552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1163288\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2023.1163288"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1163288","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"article-number":"1163288"}}